Abstract
This chapter explores the risk of second malignancies after breast radiotherapy. Meta-analyses of registry studies and randomized controlled trials have shown an elevated risk of in-field malignances after adjuvant radiotherapy for breast cancer. The relative risk increases with increasing latency post radiotherapy. The scientific literature evaluating the risk of lung cancer, esophageal cancer, sarcoma, and contralateral breast cancer in the context of patient-specific risk factors is explored in detail. The risk of second malignancy based on radiotherapy technique is also reviewed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Cahan WG, Woodward HQ, Higinbotham NL, et al. Sarcoma arising in irradiated bone. Cancer. 1958;1:3–28.
Grantzau T, Mellemkjær L, Overgaard J. Second primary cancers after adjuvant radiotherapy in early breast cancer patients: a national population based study under the Danish Breast Cancer Cooperative Group (DBCG). Radiother Oncol. 2013;106(1):42–9. https://doi.org/10.1016/j.radonc.2013.01.002.
Arlen M, Higinbotham NL, Huvos AG, et al. Radiation-induced sarcoma of bone. Cancer. 1971;28:1087–99.
Grantzau T, Overgaard J. Risk of second non-breast cancer after radiotherapy for breast cancer: a systematic review and meta-analysis of 762,468 patients. Radiother Oncol. 2015;114(1):56–65. https://doi.org/10.1016/j.radonc.2014.10.004.
Taylor C, Correa C, Duane FK, et al. Estimating the risks of breast cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials. J Clin Oncol. 2017;35(15):1641–9. https://doi.org/10.1200/JCO.2016.72.0722.
Grantzau T, Skovhus M, Væth M, Overgaard J. Risk of second primary lung cancer in women after radiotherapy for breast cancer. Radiother Oncol. 2014;111(3):366–73. https://doi.org/10.1016/j.radonc.2014.05.004.
Deutsch M, Land SR, Begovic M, Wieand HS, Wolmark N, Fisher B. The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06. Cancer. 2003;98(7):1362–8. https://doi.org/10.1002/cncr.11655.
Zablotska LB, Neugut AI. Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma. Cancer. 2003;97(6):1404–11. https://doi.org/10.1002/cncr.11214.
Milano MT, Strawderman RL, Venigalla S, et al. Non – small-cell lung cancer after breast cancer. J Thorac Oncol. 2014;9(8):1081–90. https://doi.org/10.1097/JTO.0000000000000213.
Henson KE, Mcgale P, Taylor C, Darby SC. Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer. Br J Cancer. 2012;108(1):179–82. https://doi.org/10.1038/bjc.2012.575.
Ford MB, Sigurdson AJ, Petrulis ES, et al. Effects of smoking and radiotherapy on lung carcinoma in breast carcinoma survivors. Cancer. 2003;98(7):1457–64. https://doi.org/10.1002/cncr.11669.
Kaufman EL, Jacobson JS, Hershman DL, Desai M, Neugut AI. Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol. 2008;26(3):392–8. https://doi.org/10.1200/JCO.2007.13.3033.
Depla L, Scharloo-Karels CH, de Jong M, et al. Treatment and prognostic factors of radiation-associated angiosarcoma (RAAS) after primary breast cancer: a systematic review. Eur J Cancer. 2014;50(10):1779–88. https://doi.org/10.1016/j.ejca.2014.03.002.
Torres KE, Ravi V, Kin K, et al. Long-term outcomes in patients with radiation-associated angiosarcomas of the breast following surgery and radiotherapy for breast cancer. Ann Surg Oncol. 2013;20(4):1267–74. https://doi.org/10.1245/s10434-012-2755-y.
Taghian A, de Vathaire F, Terrier P, et al. Long-term risk of sarcoma following radiation treatment for breast cancer. Int J Radiat Oncol Biol Phys. 1991;21:361–7.
Yap J, Chuba PJ, Thomas R, et al. Sarcoma as a second malignancy after treatment for breast cancer. Int J Radiat Oncol Biol Phys. 2002;52(5):1231–7.
Stovall M, Smith SA, Langholz BM, et al. Dose to the contralateral breast from radiation therapy and risk of second primary breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys. 2008;72(4):1021–30. https://doi.org/10.1016/j.ijrobp.2008.02.040.
Boice JD, Harvey EB, Blettner M, et al. Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med. 1992;326(12):781–5.
Storm HH, Andersson M, Boice JDJ, et al. Adjuvant radiotherapy and risk of contralateral breast cancer. J Natl Cancer Inst. 1992;84(16):1245–50.
Gao X, Fisher SG, Emami B. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys. 2003;56(4):1038–45. https://doi.org/10.1016/S0360-3016(03)00203-7.
Drooger JC, Akdeniz D, Pignol J-P, et al. Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age. Breast Cancer Res Treat. 2015;154(1):171–80. https://doi.org/10.1007/s10549-015-3597-7.
Hooning MJ, Aleman BMP, Hauptmann M, et al. Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer. J Clin Oncol. 2008;26(34):5561–8. https://doi.org/10.1200/JCO.2007.16.0192.
Salminen EK, Pukkala E, Kiel KD, Hakulinen TT. Impact of radiotherapy in the risk of esophageal cancer as subsequent primary cancer after breast cancer. Int J Radiat Oncol Biol Phys. 2006;65(3):699–704. https://doi.org/10.1016/j.ijrobp.2006.01.017.
Zablotska LB, Chak A, Das A, Neugut AI. Increased risk of squamous cell esophageal cancer after adjuvant radiation therapy for primary breast cancer. Am J Epidemiol. 2005;161(4):330–7. https://doi.org/10.1093/aje/kwi050.
Morton LM, Gilbert ES, Hall P, et al. Risk of treatment-related esophageal cancer among breast cancer survivors. Ann Oncol. 2012;23(12):3081–91. https://doi.org/10.1093/annonc/mds144.
Hamilton SN, Tyldesley S, Li D, Olson R, Mcbride M. Second malignancies after adjuvant radiation therapy for early stage breast cancer: is there increased risk with addition of regional radiation to local radiation? Radiat Oncol Biol. 2015;91(5):977–85. https://doi.org/10.1016/j.ijrobp.2014.12.051.
Abo-madyan Y, Hammad M, Aly MMOM, et al. Second cancer risk after 3D-CRT, IMRT and VMAT for breast cancer. Radiother Oncol. 2014;110(3):471–6. https://doi.org/10.1016/j.radonc.2013.12.002.
Santos AMC, Marcu LG, Wong CM, et al. Risk estimation of second primary cancers after breast radiotherapy. Acta Oncol. 2016;55(11):1331–7. https://doi.org/10.1080/0284186X.2016.1185150.
Zurl B, Stranzl H, Winkler P, Kapp KS. Quantification of contralateral breast dose and risk estimate of radiation-induced contralateral breast cancer among young women using tangential fields and different modes of breathing. Int J Radiat Oncol Biol Phys. 2013;85(2):500–5. https://doi.org/10.1016/j.ijrobp.2012.04.016.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Hamilton, S.N. (2019). Second Malignancies after Radiation for Breast Cancer. In: Wright, J. (eds) Toxicities of Radiation Treatment for Breast Cancer. Springer, Cham. https://doi.org/10.1007/978-3-030-11620-0_8
Download citation
DOI: https://doi.org/10.1007/978-3-030-11620-0_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-11619-4
Online ISBN: 978-3-030-11620-0
eBook Packages: MedicineMedicine (R0)